Astellas Introduces DIGITIVA™ for Heart Health
Astellas Pharma U.S., Inc. is excited to share its latest endeavor aimed at transforming heart failure management. The company has partnered with Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, to introduce DIGITIVA™, a state-of-the-art, non-invasive digital health solution tailored for heart failure patients. This innovative technology marks a significant step forward in patient care, enabling individuals to manage their heart health in collaboration with their healthcare providers.
Understanding DIGITIVA™
DIGITIVA™ is designed to empower patients in their journey to better heart health. It utilizes the CORE 500™ Digital Stethoscope, developed by Eko Health Inc., alongside an intuitive smartphone application built on the Welldoc, Inc. platform. This combination offers AI-driven personalized coaching and access to educational resources curated by the American Heart Association. Patients will benefit from enhanced data tracking regarding their health, allowing for timely interventions when necessary.
How DIGITIVA™ Functions
With DIGITIVA™, patients will receive tailored insights through clinical reports that highlight important cardioacoustic biomarkers, including S3 sounds and EMAT (electromechanical activation time). Additionally, physiological parameters will be monitored, providing clinicians with essential data that may indicate when an early intervention is needed. Such proactive measures hold the potential to greatly improve patient outcomes.
Evaluating Effectiveness Through Data
The collaboration with Desert Oasis Healthcare will gather critical data focusing on key clinical measures and cost-effectiveness from a healthcare system perspective. Furthermore, patients will participate in completing the Kansas City Cardiomyopathy Questionnaire (KCCQ) periodically. This will assess their views on heart failure symptoms and overall quality of life, enriching the feedback loop necessary for optimizing care.
Voices from Leaders
Brian Hodgkins, Pharm.D., Executive Vice President of Clinical Operations at Desert Oasis Healthcare, expressed enthusiasm about this pioneering initiative: "DIGITIVA embodies our commitment to integrating innovative technologies that enhance the lives of patients and healthcare providers alike. This tool centralizes patient care, offering essential data tracking, automated feedback, and resources for better heart health management. We are proud to lead in providing DIGITIVA access to our patients."
Furthermore, Patrick Keenan, the DIGITIVA Program Lead at Astellas, emphasized the significance of implementing DIGITIVA in a real-world context, stating, "This marks a notable milestone as the first Software as a Medical Device (SaMD) and medical device offering from Astellas in the United States. Our collaboration with Desert Oasis Healthcare is geared towards demonstrating how DIGITIVA can not only enhance the patient's role in managing their health but also aid clinicians in making critical health decisions based on personalized data."
Patient-Centric Technology
Since its FDA listing, DIGITIVA™ has drawn attention for its potential to reshape heart failure management. The focus on using technology for personal health tracking and education highlights a significant evolution in patient care models, where patients are more involved in their health outcomes.
About Astellas
Astellas Pharma Inc. is recognized for its commitment to advancing health through innovation. Operating in over 70 countries, Astellas leverages its Focus Area Approach to identify and create opportunities for developing new drugs that address significant medical needs. The company's vision extends beyond pharmaceuticals, creating Rx+® healthcare solutions by integrating expertise and novel technology. Astellas remains at the forefront of healthcare innovation, transforming scientific advancements into real value for patients.
About Desert Oasis Healthcare
Established in 1981, Desert Oasis Healthcare (DOHC) has been at the forefront of healthcare delivery in desert communities. With a commitment to comprehensive care, DOHC serves over 60,000 individuals, offering a range of services that includes primary care, clinical research, and preventive health education. Their commitment to community health is highlighted through their motto, "Your Health. Your Life. Our Passion." DOHC continues to evolve with the healthcare market, ensuring access to quality care is a priority.
Frequently Asked Questions
What is DIGITIVA™?
DIGITIVA™ is a non-invasive digital health solution designed for managing heart failure patients with the use of a digital stethoscope and smartphone app.
Who is involved in the partnership?
Astellas Pharma U.S., Inc. is partnering with Desert Oasis Healthcare to pilot the DIGITIVA™ program.
How does DIGITIVA™ benefit patients?
DIGITIVA™ helps patients track heart health data, receive personalized coaching, and access educational resources to manage their condition effectively.
What data will be collected during the partnership?
The partnership will gather data on key clinical measures, the cost of care, and patient-reported outcomes through tools like the Kansas City Cardiomyopathy Questionnaire.
What is the goal of implementing DIGITIVA™?
The goal is to improve patient outcomes in heart failure management by providing improved data tracking and timely interventions based on personalized health information.
